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Abstract
Background: The use of Complementary and Alternative Medicine (CAM) by cancer patients is
very common and varies between populations. The referenced English literature has no local study
from Africa on this subject. This study was conducted to define the prevalence, pattern of use, and
factors influencing the use of CAM by cancer patients at the University of Nigeria Teaching Hospital
Enugu (UNTH-E), Nigeria
Method: Face-to-face interviews using semi-structured questionnaire were used to determine the
use of CAM by cancer patients. All consenting cancer patients were interviewed as they presented
at the core surgical units of the UNTH- E, from June 2003 to September 2005.
Results: 160 patients were interviewed; 68 (42.5%) were males and 94 (57.5%) were females. Ages
ranged from 13–86 years. Breast, urogenital system, gastrointestinal system, and soft tissue cancers
predominated. One hundred and four patients (65.0%) have used CAM at some time during their
current cancer illness; 56 (35.0%) patients have not used any form of CAM. There were more
females than males among the non-CAM users. The use of CAM was not affected by age, marital
status, level of education, religious affiliation, or socioeconomic status. The most frequently used
CAMs were herbs (51.9%), faith/prayer healing (49.4%), aloe vera (23.1%), Forever Living Products
(16.3%), medicinal tea (14.4%), and Blackstone (12.5%). Over 23% of those who used CAM were
satisfied, but 68.3% were disappointed. Most users (67.3%) did not see any benefit from the CAM,
but 25% could describe some specific benefits. More than 21% of users reported various unwanted
effects. While 86.5% of CAM users will use orthodox medicine instead of CAM in the future, 9.6%
will use the two together to help each other. Most users (79.8%) will not repeat CAM or
recommend its use for cancer. The majority of patients (55.8%) did not mention their use of CAM
to their doctors – mostly because the doctor did not ask.
Conclusion: CAM use is common among cancer patients in Nigeria. Most users do not obtain the
expected benefits, and adverse events are not uncommon. Every clinician in the field of oncology
should ask his/her patients about the use of CAM; this knowledge will enable them to better
counsel the patients.
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Background
The innate urge among human beings to try new and
alternative ways of relieving suffering is exemplified by
the popularity of complementary and alternative reme-
dies during sickness [1-3]. This desire is more in areas in
which conventional methods have failed to provide satis-
factory solutions to diseases and ailments, such as in HIV
infection and cancer [4-6]. The need to use Complemen-
tary and Alternative Medicines is also fueled by the quest
for therapies considered more congruent to one's values,
beliefs, and philosophical orientation towards health and
life [1]. Complementary and Alternative Medicines
(CAM) are defined as medical and health care systems,
practices, and products that are not currently considered
an integral part of conventional medicine [7]. Each partic-
ular therapy may be considered complementary if it is
used in addition to conventional medical treatment; it is
viewed as an alternative if the patient decides to use it in
place of a prescribed medical treatment. Many studies
done in western countries have documented that CAM use
is both very common and varies among populations [2,3].
It is estimated that 30% to 50% of the general adult pop-
ulation of industrialized nations use one form of CAM or
another [2]. Studies of cancer patients in the industrial-
ized world documented a 7–83% prevalence rate for the
use of CAM [5,6]. The type of CAM therapies vary,
depending on age, level of income, level of education, and
perceived cause and prognosis of the disease. The use of
CAM in industrialized nations is more common among
females; young adults/middle aged individuals, members
of higher socioeconomic classes, and persons with higher
levels of education [2,3,8].
Very few studies have described the use of CAM in third
world countries. Only one study in the English literature
has evaluated the prevalence of CAM in a general popula-
tion. Singh, et al. reported a prevalence of 38.5% among
the general population of Indians living in Chatsworth,
South Africa [9]. Among the cancer populations, studies
from the developing countries are mainly from Turkey
and countries in Asia [5,10]. The prevalence of use of CAM
among cancer patients in Turkey ranged from 54.5% to
61% [11,12]. A prevalence rate of 64% was recorded in
advanced cancer patients in Taiwan [13]. These studies
from developing countries suggest that perhaps those fac-
tors that have been known to facilitate the use of CAM in
developed western countries, such as level of income and
educational attainment, may indeed be working in the
opposite direction in less developed countries. Data from
indigenous African cancer populations have consistently
been lacking in all the major reviews of use of CAM ther-
apies and remedies in the world literature [5,10].
In Nigeria, the rate of CAM use among cancer patients is
unknown. The use of traditional herbs and remedies are
however well known and relatively common [14,15].
What biomedicine considers as CAM today has been a
way of life for most Nigerians. Also, the cost of western
medical treatment and inadequate penetration of the
communities by western orthodox medicine makes CAM
more appealing to the people. In addition, there are
almost no medical malpractice litigations to limit and reg-
ulate the use of non orthodox remedies. Equally, cancer is
considered a death sentence in Nigeria [15]. Its cause in
many cases is attributed to non material causes beyond
biomedicine so that western medicine is largely seen as
ineffective in its treatment. It is therefore expected that the
use of CAM in cancer patients will be commensurately
higher than it is in western populations. We do not yet
know which factors are most critical in influencing Nige-
rian cancer patients to use CAM. We also do not know
what potential benefits or adverse outcomes can occur
when Nigerian patients on conventional western medi-
cine use standard therapy either concurrently or sequen-
tially with CAM.
This study aims to define the prevalence, pattern of use,
and factors influencing the use of CAM by cancer patients
at the University of Nigeria, Enugu (UNTH-E), Nigeria.
Methods
This was a cross-sectional study involving the direct
administration of questionnaires to all cancer patients
seen at the core surgical units of the UNTH-E, Nigeria
from June 2003 to September 2005.
The Questionnaire
The questionnaire was developed after an extensive litera-
ture search on CAM in cancer patients, as well as inquiries
within the local community on forms of CAM being used.
The initial questionnaire was refined and pre-tested with
a focus group of five cancer patients in the surgical oncol-
ogy unit of the hospital. The pilot patients were also asked
to suggest CAMs that were not listed on the questionnaire.
The final questionnaire was used to train 3 interviewers
(nurses) who administered the questionnaires through-
out the study. Interviewer training involved a 2-3-hour
session on the processes of interviewing, rationale for the
study, cancer treatment modalities, questionnaire items,
and confidentiality. Each interviewer then administered
the questionnaire to three patients. The interviewers were
debriefed by one of the investigators (RE), and responses
to the questions were cross checked for clarity and valid-
ity. A few of the question items were revised to improve
clarity while some questions were removed for lack of rel-
evance. This step also constituted the final validation of
the questionnaire [see Additional file 1].BMC Complementary and Alternative Medicine 2007, 7:28 http://www.biomedcentral.com/1472-6882/7/28
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Patient recruitment
All cancer patients managed in the surgical units of the
UNTH-E, Nigeria from June 2003 to September 2005 were
recruited into the study as long as they consented to give
the required information. Ethical clearance was obtained
from the Hospital's Institutional Review Board. Patients
whose condition precluded the ability to give informed
consent were excluded from the study. Patients were
recruited consecutively as they presented at the clinics and
wards. Information about the research was given verbally
to each patient; those who gave consent were then inter-
viewed. The first step in administering the questionnaire
was the assurance section, in which the patients were
informed that the information sought was not part of
their treatment and would in no way influence the treat-
ment of their cancer. The low level of education in our
society necessitated a structured, face-to-face interview.
The interviews took place on admission in the oncology
clinic and in the wards. The patients were informed that
they were free to decline answering any question with
which they were not comfortable. Physicians who were in
any way involved in the treatment of each patient were
not present during the interview.
The questionnaire included demographic data, such as
age, sex, marital status, socioeconomic status, and highest
level of education attained. Questions were asked about
the type of cancer, part of the body involved, previous
treatments received, and the treatment that the patient
was currently receiving. Information on the type of cancer
and stage of the disease were obtained or cross checked
from the case notes. Each patient was asked whether he/
she had used any substance not recommended by the doc-
tor to treat this cancer. Each patient was presented with a
list of known CAM remedies. The patient was then asked
whether he/she had used any of them before the diagnosis
of this cancer, during this cancer, or planned to use them
in the future. Each patient was also given an opportunity
to mention other CAMs that were not listed, but which
they had used during this illness. Patients who had used
CAM at least once during the current cancer were regarded
as CAM users; non-users had not used CAM at all during
this cancer. Those who had used CAM before in their lives
but not for this current illness were also considered non-
users. CAM practices and therapies presented to the
patients included: alternative medical systems (Chinese
medicine, Indian medicine, acupuncture, homeopathy,
ritual sacrifice, divination/incantations, specified folk
remedies); mind-body interventions (massage, manual
healing/therapeutic touch, mind-body technique, hypno-
sis, visualization/vision, meditation, and faith healing/
prayer house healing), biologically-based treatments
(herbal drugs, high dose/mega vitamins, Forever living
products, aloe vera, GNLD products, medicinal tea, green
tea, Kosagog tea, special diets/nutritional therapies, urine
therapy, mineral therapy, animal extracts, python fat,
shark cartilage, black stone, nutri water, and Tuja 1000),
manipulative and body-based methods (local surgery/
scarifications, bloodletting/coup, chiropractics, osteopa-
thy/bone setting) and energy therapy (bioelectromagnet-
ics, ozone/oxygen therapy).
CAM users were asked how frequently they used CAM,
how they got the information about the CAM, what useful
effect they were hoping to get from CAM, and how they
had actually benefited from the CAM. They were asked if
they had discontinued or hoped to discontinue CAM or
conventional treatment, or whether they had to use CAM
and orthodox treatment concurrently. The questionnaire
also asked whether there were advantages to the CAM that
the patient wished were available in conventional treat-
ment. Finally, the patients were asked whether their doc-
tor knew they were using or had used CAM, and whether
they perceived any impediments to discussing their use of
CAM freely with their doctor.
Statistical analysis
The patients were classified into CAM users and non-
users. The two groups were compared with respect to
demographic characteristics and other factors that influ-
ence the use or non use of CAM in cancer. The data were
analyzed using SPSS® statistical software version 9.0. Chi
square was used for comparison between the two groups,
with the level of significance at p = 0.05.
Results
A total of 199 patients with solid tumors were seen in the
surgical section of the hospital during this period, 160
(80.4%) of them were interviewed in the study, the rest
were too sick to participate, refused consent or were not
approached. Sixty eight (42.5%) of participants were
males, and 92 (57.5%) were females. Their ages ranged
from 13–86 years, with a mean age of 52.3 years and a
median age of 51.0 years. The majority of the patients
have been on treatment for one month-two years. More
than half of the patients (56.9%) have had surgery, 28.8%
have received anti-cancer drugs, and 2.5% have had radi-
otherapy. At the time of the interview, 20.6% were on
admission for surgery, 50.6% were receiving chemother-
apy, and 3.8% were on symptomatic palliative therapy.
The distribution of cancers represented the typical spec-
trum of patients we usually see in our oncology clinic and
surgical wards: breast cancer (36.3%); urogenital tract
cancers (19.4%); gastrointestinal tract cancers (16.9%);
soft tissue tumors (7.5%). Other types included respira-
tory tract cancers (2.5%), head and neck cancers (1.9%),
gynecological malignancies (1.9%), and lymphomas
(0.6%).BMC Complementary and Alternative Medicine 2007, 7:28 http://www.biomedcentral.com/1472-6882/7/28
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When asked whether they have used anything other than
what their doctors recommended in treating the cancer,
91 patients (56.9%) said they have and 65 patients
(40.6%) said they have not. However, when each patient
was presented with examples of individual CAMs, 104
(65.0%) of the patients said they have used at least one of
them at some time during this cancer; 56 (35.0%) patients
have not used any form of CAM at all.
Table 1 compares the demographic characteristics of CAM
users and non users. More females were in the group of
patients that have never used any form of CAM during the
current illness (p = 0.052). While more of the "never mar-
ried" patients have used CAM, a greater number of
patients who were divorced, separated, or widowed were
found to be non-CAM users; these differences were not
statistically significant. Patients who had no formal edu-
cation were more likely to have used CAM than those who
had up to post-primary level of education or more. Again,
the differences were not significant. There were more
Catholics among the non-CAM users (67.8% vs. 57.7%),
and disproportionately more of the Pentecostals were
found among the CAM users (22.1% vs. 8.9%). These dif-
ferences were also not significant. Other religious groups
like Anglicans, Traditional religious adherents and Mus-
lims were evenly distributed between the CAM users and
non users.
The most commonly used forms of CAM (Table 2) were
the biological-based treatments, including herbs (51.9%),
aloe vera (23.1%), Forever Living Products (16.3%),
medicinal tea (14.4%), and black stone (12.5%). Prayer/
faith healing (39.4%) was the second most common CAM
after herbs. The alternative medical systems, such as
energy techniques, manipulation, and body-based meth-
ods, were rarely used. Other CAMs used by small number
of patients included ginger (1.9%), garlic (1.9%), Noni
(1.9), mineral therapy (1.9%), bloodletting (1.9%), local
surgery/scarifications (1.9%), divinations/incantations
(1%), qamwood oil (okwuma) (1%), urine therapy (1%),
magnetic water (1%), tuja 1000 (1%), uda (1%), mind-
body technique (1%), manual healing/touch (1%) and
green tea (1%). In particular, nutri water, kosagog tea,
shark cartilage, animal extracts, hypnosis, psychic therapy,
mental imagery, acupuncture, Indian medicine, chiro-
practics, bone setters/osteopathy, bioelectrical magnetism
and oxygen/ozone therapy were never used by our
patients.
Most of the respondents (77.9%) used CAM daily; others
use them weekly (1.9%) or occasionally (6.7%), while
5.8% used them only once. The number of CAMs used by
each patient varied from one to nine different types. The
majority of the patients (61.5%) have used two or more
types, 33.7% have used only one type, while 4.8% could
not pick out the exact ones they used during this cancer.
The majority of the patients (39.9%) have been on CAM
for less than a month, 15.3% have used it for one to six
months, 13.7% have used it for more than 6 months to
one year, and 10.8% have used it for more than one year.
Half of those using CAM (50.0%) have visited CAM prac-
titioners several times during the course of this illness,
Table 2: Types of CAM used by patients
Biological 
products
Frequency of 
use (%)
Mind- body 
systems
Frequency (%)
Herbs 54 (51.9) Faith healing/
prayer
40 (39.4)
Aloe vera 24 (23.1) Visualization 9 (8.7)
Forever living 
products
17 (16.3) meditation 7 (6.7)
Medicinal tea 15 (14.4)
Python fat 8 (7.7) Alternative 
systems
Frequency
Special diet/
Nutritional 
therapy
7 (6.7) Chinese 
medicine
9 (8.7)
High dose 
vitamins
5 (4.8) Homeopathy 4 (3.8)
GNLD product 4 (3.8) ritual sacrifice 3 (2.9)
Tianshi 3 (2.9)
Others Frequency
Black stone 13 (12.5)
massage 4 (3.8)
Mustard seed 3 (2.9)
Table 1: Demographic characteristics of CAM users and non 
users
Parameter CAM users 
(%)
Non CAM 
users (%)
significance
Sex Male 50 (48.1) 18 (32.1) P = 0.052
Female 54 (51.9) 38 (67.9)
Mean age 51.9 yrs 53.0 yrs P > 0.05
Marital 
status
Married 81 (77.9) 40 (71.4) P = 0.050
Not 
married
11 (10.6) 2 (3.6)
Widowed 12 (11.5) 11 (19.6)
Divorce/
separated
-2  ( 3 . 6 )
No 
response
-1  ( 1 . 8 )
Level of 
education
Non 14 (13.5) 5 (8.9) P > 0.05
Primary 26 (25.0) 14 (25.0)
Post 
primary
28 (26.9) 19 (33.9)
Tertiary 32 (30.8) 18(32.1)
No entry 4 (3.8)
Socioecono
mic status
Low 
income
49 (47.1) 24 (42.9) P > 0.05
Middle 
income
46 (44.2) 26 (46.4)
High 
income
5 (4.8) 1 (1.8)
No entry 4 (3.8) 5 (8.9)BMC Complementary and Alternative Medicine 2007, 7:28 http://www.biomedcentral.com/1472-6882/7/28
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32.7% visited CAM practitioners once, and 7.7% have not
visited any practitioner even though they were using
CAM.
Most of the patients expected CAM to directly treat/cure
their cancer (63.5%). Other expectations (Table 3)
include: "just to do anything that will help fight the can-
cer" (17.3%); to improve physical well being (10.7%); to
improve psychological/emotional well being (4.9%);
relief of symptoms of cancer (2.9%); to improve body's
ability to fight the cancer (1.9%). Most of the patients did
not observe any benefit from CAM (67.3%), 4.8% of the
respondents noticed some benefit they could not specify,
25% thought they experienced some specific benefits.
Specific benefits reported include relief of pain (8
patients), feels healthy/good/improved/refreshes my
body (5), reduction in swelling (3), prayer sustains my life
(2), constipation relieved (2), helps to build my immune
system/protects my body from other illness (2), healed
wound (1), stopped bleeding in urine (1), felt it washed
off disease from my stomach (1), relieved fever (1),
stopped pushing effect in rectum (1), python fat cleared
keloid at operation site (1).
The majority of the patients (63.4%) did not experience
any perceived unwanted effects from CAM; 5.8% reported
unwanted effects but were not specific, while 22 patients
(21.2%) reported various specific unwanted effects that
include slimming down (3 patients), anorexia, nausea
and vomiting (3 patients), weakness, malaise, generalized
body discomfort (3 patients), and diarrhea/mucoid stool
(3 patients). Other unwanted reactions included bleeding
from wound and urine (2 patients), cough (2 patients),
hotness of the body (2 patients), worsened stomach upset
(2 patients), skin excoriations from balm (1 patient), con-
stipation with frequent urination (1 patient), and light-
headedness (1 patient). While twenty-four patients
(23.1%) were either very satisfied (1.9%) or satisfied
(21.2%) with CAM, 68.3% said they were disappointed
with it. Most patients (79.8%) said they would not repeat
CAM or recommend it to someone they know for a similar
condition, but 16.3 would recommend it. The majority of
patients did not express an opinion (43.3%) or did not
wish (38.5%) to include any aspect of CAM in orthodox
medical practice. Among those who wanted some aspects
of CAM to be used in conventional medicine (17.3%), the
popular wishes were: Forever living products – 5.8%,
prayers – 4.0%, and aloe vera – 2.9%.
The majority of CAM users (49.0%) did not have supervi-
sors or guides for the CAM, but 41.3% had supervisors or
someone guiding them. While 86.5% of the patients will
continue to use orthodox medicine instead of CAM for
this cancer, 9.6% said they will use the two together to
help each other. Five respondents said that they had at
one time or another abandoned conventional treatment
in favor of CAM because they believed that CAM would
cure them. About a third (32.7%) of CAM users discussed
it with their doctors while 55.8% did not mention the
CAM they were using to their doctors. Most CAM users
(55.8%) declined to give reasons for their failure to men-
tion the CAM to their doctors. The most common reasons
given by those who answered the question were that the
doctor did not ask (28.3%), or no specific reason
(11.6%), or they felt the doctor would be unhappy, scold
them, or tell them to stop (2.9%).
The respondents' main sources of information on CAM
were family members (30.8%), friends (30.8%), and
CAM practitioners (22.1%). Most patients obtained their
CAM supply from the CAM practitioner (55.9%). Other
significant sources included relations (13.5%), churches
(10.6%), friends (8.7%), and the open market (7.7%).
Discussion
To the best of our knowledge, this is the first study of the
use of CAM therapies by cancer patients in any indigenous
African population. The prevalence of CAM use among all
cancer patients varies widely, even between reports on the
same population. Figures have ranged from 7% to 83%
[5,6], but the average rate across adult studies has been
31.4% [5]. Our own prevalence rate of 65.0% is one of the
highest reported in the literature. While the definition of
what is considered CAM therapy in each study accounts
for some of these variations, we believe that the high prev-
alence rate among our patients can be explained by the
Table 3: Expected and perceived (actual) benefits from CAM
Expected 
benefits
Frequency 
(%)
Actual 
benefits
Frequency 
(%)
Directly treat/
cure the cancer
66 (63.5) No benefit 70 (67.3)
To do 
everything 
possible for this 
cancer
18 (17.3) Yes, can't 
specify
5 (4.8)
Improve 
physical well 
being
11 (10.7) Yes with 
specific benefits
26 (25.0)
Improve 
psychological 
and emotional 
well being
5 (4.9) No response 3 (2.9)
Relieve cancer 
symptoms
3 (2.9)
Boost body's 
ability to fight
2 (1.9)
Clean up wound 1 (1.0)
Detect the type 
of disease and 
treat
1 (1.0)
No response 6 (5.8)
Total 104 (100)BMC Complementary and Alternative Medicine 2007, 7:28 http://www.biomedcentral.com/1472-6882/7/28
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traditional nature of our society, our cultural and religious
beliefs and practices, the cost of western conventional
treatment and our peoples' understanding of cancer as a
disease. Nigeria is a developing country, predominantly
traditional in outlook with 51.7% of the population liv-
ing in rural areas and 57% of the people surviving on less
than 1 dollar per day [16]. The current emphases on west-
ern biomedicine notwithstanding, traditional medical
practices are still the mainstream ways to treat diseases
and ailments for many Nigerians. Some individuals actu-
ally regard western biomedicine as an alternative or a
complement to traditional medicine. While the two sys-
tems run parallel in the Nigerian environment, switching
from one form to the other is a common phenomenon
and depends on which of them each patient and the rela-
tions believe is most suitable for a particular condition.
Also western biomedicine is expensive and relatively not
accessible, compared to traditional forms of treatment. It
is, therefore, not surprising that most patients resort to
herbs and spiritual healing, upon which they have relied
since antiquity. Many patients still regard cancer as due to
spiritual forces beyond the reach of biomedicine. In addi-
tion, most of our cancer patients die even after receiving
conventional western medical treatment. This gives peo-
ple the impression that conventional treatments are not
better. It therefore makes sense for them to try "alternative
treatments" first, or to use them in combination with
western biomedicine to get all the benefits possible. Stud-
ies from some other traditional societies such as Turkey
and Taiwan documented similar high prevalence rates
[11-13].
Conflicting findings have been reported about factors that
affect the use of CAM therapies. Some studies have found
associations between age, gender, socioeconomic status,
income, and level of education. Studies in developed
western countries found that women, in both the general
population and among cancer patients, have higher prev-
alence of use than men, and that the peak age of use is
among young adults/middle aged [3,10]. Also, higher
income, higher level of education, and higher socioeco-
nomic status have been linked to higher prevalence of
CAM use [3,10]. Among a general population of Indians
in Chatsworth, South Africa, Singh, et al. found no demo-
graphic factor to be a significant predictor of use of CAM
[8]. Malik, et al. reported no significant influence of age,
level of education, and socioeconomic status in a Turkish
population of cancer patients, but found that patients
from large families and women were more likely to use
CAM [12]. Ceylan, et al. in a more recent survey in Turkey
found no association between the use of CAM and age,
gender, or marital status among cancer patients; they did,
however, report an inverse relationship between use of
CAM and socioeconomic status [11]. While we found a
non-significant tendency for use of CAM to decrease with
increasing levels of education, there was no association
between use of CAM and age, marital status, or socioeco-
nomic status in our patients. More of our women were
non-CAM users. This finding stands out from all reports in
the literature. We theorize that this is due to a cultural ten-
dency of males from our population (as opposed to our
females) to avoid western hospitals and try all forms of
traditional therapy before resorting to conventional treat-
ment.
CAM use in most developed countries in which health
insurance is operational seems to be more among the bet-
ter educated and higher socioeconomic classes since
patients have to pay for the CAM privately. This trend does
not exist in most poor developing countries where CAM is
cheap and health insurance is nonexistent. Poor patients
in developing countries who must pay out of their pocket
for either CAM or the more expensive conventional treat-
ment are more likely to try CAM first. It is also noteworthy
that most studies from the developed world tend to be
skewed towards the middle and higher income classes,
and under-represent the lower socioeconomic class [3].
The demographics of the lower class however, are more
likely to resemble the situation in resource-poor countries
with respect to the use of CAM.
The most commonly used form of CAM in Nigeria is
herbal preparations, followed by faith healing/prayer
house healing. Singh, et al. recorded that herbs and spirit-
ual healing were the two most common forms of CAM
used among Indians in South Africa [9]. In the US, relax-
ation techniques, herbal medicine, massage, and chiro-
practics were the most commonly used forms of CAM
within the general population [2]. Among cancer patients,
spiritual practices, vitamins and herbs, movement and
physical therapies, and mind/body approaches were most
commonly used [8,17]. Herbal preparations have also
been reported to be the leading CAM used among cancer
patients in Turkey [11,12]. In the UK, the most common
forms were healing, relaxation, and visualization [18].
Traditional African communities have always used herbs
to cure diseases. Thus, it is not surprising that this practice
has persisted and even extended to include newer prepa-
rations of biological products, such as aloe vera products,
Forever living products, GNLD (Golden Neo life Diamite)
products, medicinal tea etc.
The high prevalence of faith and prayer house healing
among Nigerian patients mirrors the attachment of peo-
ple of African ancestry to spiritual and transcendental
beliefs. Some of the patients rely completely on prayers
and faith for their healing. Such patients are usually
brought to the hospital when the disease is widely meta-
static or locally advanced. Deaths in such cases are inevi-
table, but also reinforce the belief that WesternBMC Complementary and Alternative Medicine 2007, 7:28 http://www.biomedcentral.com/1472-6882/7/28
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biomedicine is not helpful in treating cancer. Religious
affiliations appear to influence the pattern of use of CAM
in our population, but not at statistically significant levels.
More of the Pentecostals in our population used CAM
compared to other groups and this is accounted for
mainly by use of faith/prayer house healing. The high pro-
portion of Catholics among our study population
explains the increased prevalence in the use of religious
relics and items such as black stone, olive oil, and mustard
seed.
Most of our patients expected CAM to directly treat or cure
their cancers (63.5%). Similar findings were observed
among cancer patients in the U.K [18], and Turkey [11]. In
contrast, cancer patients in the US use CAM primarily to
improve quality of life, boost the immune system, and
relieve symptoms with only one-third of patients expect-
ing a direct curative treatment from the CAM [8]. The high
rate of disappointment (68.3%) that our patients
expressed about the performance of CAM in cancer is
explained by the fact that most of them were hoping for a
direct treatment/cure; it also explains their reluctance
(79.8%) to recommend it to someone else or use it in the
future for cancer treatment. Indeed, the fact that only
2.9% of users among our patients got information about
their CAM from other patients supports the data that most
of them were disappointed and will not recommend it or
use it in future. CAM users in Nigeria rely on family mem-
bers, friends, and CAM practitioners for their information
about CAM. Surprisingly, none of our patient said that
they received information on CAM from the mass media
– despite the fact that CAM practitioners often use it as a
means to promote their products.
Up to 25% of our respondents claimed they got some spe-
cific benefits from CAM; almost an equal number
(23.1%) were either very satisfied or satisfied with the
results. Some of the benefits remain subjective and unver-
ifiable – for example: "it makes me feel healthy"; "it helps
my body fight cancer"; "it sustains my life"; "it cleanses
my body." While some of the observed benefits, such as
relief of pain and reduction in size of lumps, can be veri-
fied, the fact that CAM is used in conjunction with con-
ventional treatment casts doubts on these claims.
Only 21.2% of respondents reported unwanted effects
from CAM, supporting the assumption that these agents
are natural and safe. Most of the claimed adverse effects
are very difficult to distinguish from the natural manifes-
tations or progression of advanced malignancies. Some
specific adverse effects are however indisputable. Over the
course of this study, we observed two cases of full thick-
ness chemical burns following application of herbs on the
skin. CAM's potential for serious harm is evidenced by the
fact that five of our patients abandoned conventional
treatment in favor of CAM. While most CAM may not be
directly injurious to the patient, the greatest harm may be
in delaying or preventing patients from coming for poten-
tially curative cancer treatment at the earliest possible
time.
Most of our patients who used CAM (55.8%) did not tell
their doctors about it – mainly because the doctor failed
to ask (28.3%). This finding is in keeping with reported
disclosure rates of 39%–45.8% in studies of cancer
patients in the US [4], UK [18] and Indians in South Africa
[11]. The fact that most patients will not disclose their use
of CAM unless asked makes it necessary for every oncolo-
gist to routinely ask cancer patients whether they use
CAM, the ones they use, and how they use them. A small
proportion of our patients did not inform their doctors
because they feared that the doctor would scold them or
tell them to stop it. This finding underscores the necessity
for oncologists to refrain from being judgmental about
patients' use of CAM if they are to learn the truth.
The main weakness of our study is that it is a hospital-
based survey, thereby excluding patients who have aban-
doned conventional treatment completely or never used it
at all. Also our questionnaire was developed after review
of existing studies, most of which were from industrial-
ized western countries. While we made it relevant to our
local environment by incorporating local CAMs and local
ideas on CAM, there is still the possibility that some valu-
able insights on the Nigerian patients' attitudes to bio-
medicine and traditional medical practices (regarded as
CAM by biomedicine) might not be conveyed by the
method we used. We believe such insights may be better
gained through qualitative in-depth individual and focus
group interviews. Also, our patient population does not
represent all cancers in the hospital. Hematological malig-
nancies, gynecological malignancies, and some subspe-
cialty areas were under-represented because these patients
are not managed within the core surgical oncology sec-
tions in our hospital. These shortcomings notwithstand-
ing, we believe the study gives a reliable picture of the use
of CAM among cancer patients in a teaching hospital in
Nigeria.
Conclusion
The prevalence of CAM use in cancer patients in Nigeria is
one of the highest in the world. While it tends to be less
common in females, it is not affected by age, marital sta-
tus, socioeconomic status, or level of education. Herbs
and faith healing/prayer house healing are the most com-
mon forms of CAM. Most of the patients expect to be
cured and are disappointed with the results of CAM. A
majority of the patients who used CAM did not volunteer
that information to their doctors, primarily because the
doctors did not ask about it. We believe that every clinicalPublish with BioMed Central    and   every 
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oncologist should be aware of the prevalence of use of
CAM in his/her environment. The physician should find
out the composition of the various therapies and know
which ones are harmful to patients. Patients should rou-
tinely be asked about CAM and its use as part of every can-
cer patient's evaluation.
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